Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

NIH research contributed to all new FDA-approved drugs from 2010 to 2016, report says

by Andrea Widener
February 19, 2018 | A version of this story appeared in Volume 96, Issue 8

NIH-funded research was associated with all 210 new drugs approved by the FDA between 2010 and 2016, a contribution that totals over $100 billion, a new study claims. The paper by researchers at Bentley University found over 2 million publications in PubMed, NIH’s publication indexing service, related to the new molecular entities or their biological targets (Proc. Natl. Acad. Sci. USA 2018, DOI:10.1073/pnas.1715368115). Over 90% of that research was basic science related to the biological target of the drug. Previous estimates have suggested far lower contributions by NIH to new drug discovery. The authors say this is probably because publications are more likely to reflect basic research than patents or New Drug Applications. “Published research, taken as a whole, reflects the advancing forefront of knowledge from which new drugs are discovered and developed,” the paper says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.